Kern WV - Search Results

1

Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps.

Bohnert JA, Kern WV. Bohnert JA, et al. Among authors: kern wv. Antimicrob Agents Chemother. 2005 Feb;49(2):849-52. doi: 10.1128/AAC.49.2.849-852.2005. Antimicrob Agents Chemother. 2005. PMID: 15673787 Free PMC article.

2

Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromised patients.

Kern WV, Markus A, Andriof E. Kern WV, et al. Eur J Clin Microbiol Infect Dis. 1994 Feb;13(2):161-5. doi: 10.1007/BF01982191. Eur J Clin Microbiol Infect Dis. 1994. PMID: 8013490

3

Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.

Kern WV, Andriof E, Oethinger M, Kern P, Hacker J, Marre R. Kern WV, et al. Among authors: kern p. Antimicrob Agents Chemother. 1994 Apr;38(4):681-7. doi: 10.1128/AAC.38.4.681. Antimicrob Agents Chemother. 1994. PMID: 8031031 Free PMC article.

4

A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.

Kern WV, Hay B, Kern P, Marre R, Arnold R. Kern WV, et al. Among authors: kern p. Antimicrob Agents Chemother. 1994 Mar;38(3):465-72. doi: 10.1128/AAC.38.3.465. Antimicrob Agents Chemother. 1994. PMID: 8203838 Free PMC article. Clinical Trial.

5

Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers.

Oethinger M, Conrad S, Kaifel K, Cometta A, Bille J, Klotz G, Glauser MP, Marre R, Kern WV. Oethinger M, et al. Among authors: kern wv. Antimicrob Agents Chemother. 1996 Feb;40(2):387-92. doi: 10.1128/AAC.40.2.387. Antimicrob Agents Chemother. 1996. PMID: 8834885 Free PMC article.

6

gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli.

Conrad S, Oethinger M, Kaifel K, Klotz G, Marre R, Kern WV. Conrad S, et al. Among authors: kern wv. J Antimicrob Chemother. 1996 Sep;38(3):443-55. doi: 10.1093/jac/38.3.443. J Antimicrob Chemother. 1996. PMID: 8889719

7

Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli.

Oethinger M, Kern WV, Goldman JD, Levy SB. Oethinger M, et al. Among authors: kern wv. J Antimicrob Chemother. 1998 Jan;41(1):111-4. doi: 10.1093/jac/41.1.111. J Antimicrob Chemother. 1998. PMID: 9511045

8

Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli.

Oethinger M, Podglajen I, Kern WV, Levy SB. Oethinger M, et al. Among authors: kern wv. Antimicrob Agents Chemother. 1998 Aug;42(8):2089-94. doi: 10.1128/AAC.42.8.2089. Antimicrob Agents Chemother. 1998. PMID: 9687412 Free PMC article.

9

Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.

Oethinger M, Kern WV, Jellen-Ritter AS, McMurry LM, Levy SB. Oethinger M, et al. Among authors: kern wv. Antimicrob Agents Chemother. 2000 Jan;44(1):10-3. doi: 10.1128/AAC.44.1.10-13.2000. Antimicrob Agents Chemother. 2000. PMID: 10602715 Free PMC article.

10

Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli.

Kern WV, Oethinger M, Jellen-Ritter AS, Levy SB. Kern WV, et al. Antimicrob Agents Chemother. 2000 Apr;44(4):814-20. doi: 10.1128/AAC.44.4.814-820.2000. Antimicrob Agents Chemother. 2000. PMID: 10722475 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

369 results

Search Page

Filters